Komori
Governance4536SANTEN PHARMACEUTICAL CO.,LTD.Pharmaceuticals

Report on Corporate Governance 2026/06/26

The Board of Directors comprises 7 directors, including 4 outside directors, and the Audit & Supervisory Board comprises 4 Audit & Supervisory Board Members, including 3 outside members. The company has established voluntary committees, including a Nomination Committee and an Executive Compensation Committee.

Worth reading
59In focus
Scored from 1 of 5 sections
Direction
Neutral
Direction inferred from the company’s description.
Scale
—
Displayed only when the document provides numerical figures.
Wording
Definitive
How definitive the wording is.

Governance structure

Company with an Audit & Supervisory Board
Number of directorsTotal of 7 directors, including 4 outside directors
Committee7
Nomination CommitteeExecutive Compensation CommitteeStrategy Review CommitteeSustainability CommitteeCompliance CommitteeRisk Management CommitteeCrisis Management Committee
Governance structure
ItemDetails
Corporate Governance StructureCompany with an Audit & Supervisory Board
Number of directorsTotal of 7 directors, including 4 outside directors
CommitteeNomination Committee (proportion of outside members: Not disclosed), Executive Compensation Committee (proportion of outside members: Not disclosed), Strategy Review Committee (proportion of outside members: Not disclosed), Sustainability Committee (proportion of outside members: Not disclosed), Compliance Committee (proportion of outside members: Not disclosed), Risk Management Committee (proportion of outside members: Not disclosed), Crisis Management Committee (proportion of outside members: Not disclosed)
Items this document does not state (5)
Number of independent officersPolicy on cross-shareholdingsTakeover defensesControlling shareholderChanges this time

These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.

The reasons the company gives

The company's own explanation, not something inferred from the numbers.

The report does not state the reasons for the corporate structure or the establishment of the committees.

How to read this page

This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.
Report on Corporate Governance 2026/06/26 | SANTEN PHARMACEUTICAL CO.,LTD. (4536) timely disclosure | Komori